NHRA – issues updated “Health Products Licensing Guideline” V 3
NHRA issues updated “Health Products Licensing Guideline” (V 3.0) 🔍 What’s new:
NHRA issues updated “Health Products Licensing Guideline” (V 3.0) 🔍 What’s new:
NHRA issues updated “Medicine Licensing Guideline” (Version 4.1) 🔍 What’s new:
NHRA issues updated “Medicine Renewal Guideline” (Version 2.1) & “Medicine Variations Guideline”
NHRA issues updated “International Manufacturing Site Licensing Procedure” Guideline (Version 1.6)
SFDA Issues Final CMC Guidance for Human Gene Therapy Clinical Trial Applications.
SFDA issues updated “Verification & Abridged Pathways” Guideline (Version 3.0 — Issued
The Saudi Food & Drug Authority (“SFDA”) has issued a new guidance
OMAN MOH issued new Circular No. 194/2025 – Mandatory Renewal of Pharmaceutical
Kuwait MoH issues “Guideline on the Preparation & Submission of eCTD Dossiers”
Qatar MOPH issues new Guideline on Braille Requirements for Labeling Information of